Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

NCT ID	NCT05006794
Title	Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
Recruitment	Recruiting
Gender
Phase	Phase I
Variant Requirements	Yes
Sponsors	Gilead Sciences
Indications	lung small cell carcinoma endometrial cancer lung non-small cell carcinoma gastric adenocarcinoma gastrointestinal stromal tumor Kaposi's sarcoma thyroid gland follicular carcinoma malignant mesothelioma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma triple-receptor negative breast cancer transitional cell carcinoma esophageal cancer clear cell renal cell carcinoma ovary epithelial cancer colorectal cancer cervical cancer hepatocellular carcinoma breast cancer prostate cancer
Therapies	GS-9716 + Sacituzumab govitecan-hziy GS-9716 Docetaxel + GS-9716
Age Groups:	senior \| adult
Covered Countries	USA